The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations

scientific article published on 19 June 2013

The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TRF.12297
P698PubMed publication ID23781978

P50authorPaul M NessQ107569672
P2093author name stringYi Huang
Jing Liu
Nan Guo
David J Wright
Hua Shan
Qilu Yu
Jingxing Wang
Mei Huang
Fuzhu Yao
Guoxin Wen
Julin Li
Xiuqiong Wen
Yunlai Lü
Hongli Ma
Mei-hei-li Tiemuer
Weilan He
Xiangming Zhu
Xinhong Bi
Zhongmin Zhou
Zhongqiao Yun
NHLBI Retrovirus Epidemiology Donor Study-II International Component
Ru'an Cao
Tonghan Yang
P2860cites workThe prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptQ30403548
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlatesQ33576933
Hepatitis C seroprevalence and associated risk factors, Anyang, ChinaQ33800604
Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysisQ33866387
Who donates blood at five ethnically and geographically diverse blood centers in China in 2008.Q34121100
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.Q34346207
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysisQ34779247
Blood banking in ChinaQ35024880
Hepatitis C virus infection, Linxian, ChinaQ35804327
The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availabilityQ36252455
Injection drug use and HIV/AIDS transmission in ChinaQ36342046
Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virusQ36403550
Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.Q36562355
Systematic review of HIV and HCV infection among drug users in ChinaQ37487292
Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysisQ37617380
The risk of transfusion-transmitted infections in sub-Saharan AfricaQ37618324
Global burden of hepatitis C: considerations for healthcare providers in the United StatesQ42981508
Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.Q43036225
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor populationQ43040535
A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testingQ43041674
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donorsQ44931522
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Q44979610
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern ChinaQ45654072
Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood ServicesQ48081521
International application of the incidence rate/window period model.Q53307878
P433issue10 Pt 2
P921main subjectHepatitis C virusQ708693
viral persistenceQ44134905
viral transmissionQ123924092
P304page(s)2489-2497
P577publication date2013-06-19
P1433published inTransfusionQ15758500
P1476titleThe persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations
P478volume53

Reverse relations

cites work (P2860)
Q30365797Hepatitis C virus infection in China: an emerging public health issue.
Q37350196Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis
Q41669992Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers
Q36157247Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China
Q36187319Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China
Q33432155Which is safer source plasma for manufacturing in China: apheresis plasma or recovered plasma?

Search more.